Long term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinoma

dc.contributor.authorKim, W. R.
dc.contributor.authorBerg, Thomas
dc.contributor.authorLoomba, Rohit
dc.contributor.authorSchall, Raul Aguilar
dc.contributor.authorDinh, Phillip
dc.contributor.authorYee, Leland J.
dc.contributor.authorMartins, Eduardo B.
dc.contributor.authorFlaherty, John F.
dc.contributor.authorButi, Maria
dc.contributor.authorMarcellin, P.
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.date.accessioned2022-11-18T08:12:20Z
dc.date.available2022-11-18T08:12:20Z
dc.date.issued2013-04
dc.identifier.citationKim, W. R. vd. (2013). "Long term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinoma". Journal of Hepatology, 58, Supplement 1, S19-S19.en_US
dc.identifier.endpageS19tr_TR
dc.identifier.issn0168-8278
dc.identifier.startpageS19tr_TR
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(13)60045-8
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0168827813600458
dc.identifier.urihttp://hdl.handle.net/11452/29479
dc.identifier.volume58, Supplement 1tr_TR
dc.identifier.wos000322983000044tr_TR
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.journalJournal of Hepatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleLong term tenofovir disoproxil fumarate (tdf) therapy and the risk of hepatocellular carcinomaen_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections